Gatz M, Reynolds CA, Fratiglioni L, Johansson B, Mortimer JA, Berg S, et al. Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry. 2006;63:168–74.
Article
PubMed
Google Scholar
Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer’s disease. Nat Genet. 2009;41:1088–93.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo MM, et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease. Nat Genet. 2011;43:429–35.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer’s disease. Nat Genet. 2009;41:1094–9.
Article
CAS
PubMed
Google Scholar
Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat Genet. 2013;45:1452–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J, et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer’s disease. Nat Genet. 2011;43:436–41.
Article
CAS
PubMed
PubMed Central
Google Scholar
Seshadri S, Fitzpatrick AL, Ikram MA, DeStefano AL, Gudnason V, Boada M, et al. Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA. 2010;303:1832–40.
Article
CAS
PubMed
PubMed Central
Google Scholar
Liu CC, Kanekiyo T, Xu H, Bu G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol. 2013;9:106–18.
Article
CAS
PubMed
PubMed Central
Google Scholar
Witoelar A, Rongve A, Almdahl IS, Ulstein ID, Engvig A, White LR, et al. Meta-analysis of Alzheimer’s disease on 9,751 samples from Norway and IGAP study identifies four risk loci. Sci Rep. 2018;8:18088.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, et al. Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing. Nat Genet. 2019;51:414–30.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jansen IE, Savage JE, Watanabe K, Bryois J, Williams DM, Steinberg S, et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk. Nat Genet. 2019;51:404–13.
Article
CAS
PubMed
PubMed Central
Google Scholar
Katsumata Y, Nelson PT, Estus S, Fardo DW. Translating Alzheimer’s disease-associated polymorphisms into functional candidates: a survey of IGAP genes and SNPs. Neurobiol Aging. 2019;74:135–46.
Article
CAS
PubMed
Google Scholar
Jiang Q, Hu Y, Liu G. Association of Alzheimer disease susceptibility variants and gene expression in the human brain. JAMA Neurol. 2016;73:1255.
Article
PubMed
Google Scholar
Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al. Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:280–92.
Article
PubMed
PubMed Central
Google Scholar
Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA research framework: toward a biological definition of Alzheimer’s disease. Alzheimers Dement. 2018;14:535–62.
Article
PubMed
PubMed Central
Google Scholar
Apostolova LG, Risacher SL, Duran T, Stage EC, Goukasian N, West JD, et al. Associations of the top 20 Alzheimer disease risk variants with brain amyloidosis. JAMA Neurol. 2018;75:328–41.
Article
PubMed
PubMed Central
Google Scholar
Stage E, Duran T, Risacher SL, Goukasian N, Do TM WJD, et al. The effect of the top 20 Alzheimer disease risk genes on gray-matter density and FDG PET brain metabolism. Alzheimers Dement (Amst). 2016;5:53–66.
Article
Google Scholar
Franzmeier N, Rubinski A, Neitzel J, Ewers M. The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory. Nat Commun. 2019;10:1766.
Article
PubMed
PubMed Central
CAS
Google Scholar
Ramos de Matos M, Ferreira C, Herukka SK, Soininen H, Janeiro A, Santana I, et al. Quantitative genetics validates previous genetic variants and identifies novel genetic players influencing Alzheimer’s disease cerebrospinal fluid biomarkers. J Alzheimers Dis. 2018;66:639–52.
Article
CAS
PubMed
Google Scholar
Deming Y, Li Z, Kapoor M, Harari O, Del-Aguila JL, Black K, et al. Genome-wide association study identifies four novel loci associated with Alzheimer’s endophenotypes and disease modifiers. Acta Neuropathol. 2017;133:839–56.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ramasamy A, Trabzuni D, Guelfi S, Varghese V, Smith C, Walker R, et al. Genetic variability in the regulation of gene expression in ten regions of the human brain. Nat Neurosci. 2014;17:1418–28.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yu JT, Li JQ, Suckling J, Feng L, Pan A, Wang YJ, et al. Frequency and longitudinal clinical outcomes of Alzheimer’s AT(N) biomarker profiles: a longitudinal study. Alzheimers Dement. 2019;15:1208–17.
Article
PubMed
Google Scholar
Jack CR Jr, Wiste HJ, Weigand SD, Therneau TM, Lowe VJ, Knopman DS, et al. Defining imaging biomarker cut points for brain aging and Alzheimer’s disease. Alzheimers Dement. 2017;13:205–16.
Article
PubMed
Google Scholar
McKenzie M, Henders AK, Caracella A, Wray NR, Powell JE. Overlap of expression quantitative trait loci (eQTL) in human brain and blood. BMC Med Genet. 2014;7:31.
Google Scholar
Roshchupkin GV, Adams HH, van der Lee SJ, Vernooij MW, van Duijn CM, Uitterlinden AG, et al. Fine-mapping the effects of Alzheimer’s disease risk loci on brain morphology. Neurobiol Aging. 2016;48:204–11.
Article
PubMed
Google Scholar
Allen M, Kachadoorian M, Carrasquillo MM, Karhade A, Manly L, Burgess JD, et al. Late-onset Alzheimer disease risk variants mark brain regulatory loci. Neurol Genet. 2015;1:e15.
Article
PubMed
PubMed Central
CAS
Google Scholar
Allen M, Zou F, Chai HS, Younkin CS, Crook J, Pankratz VS, et al. Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology. 2012;79:221–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cho H, Kim JH, Kim C, Ye BS, Kim HJ, Yoon CW, et al. Shape changes of the basal ganglia and thalamus in Alzheimer’s disease: a three-year longitudinal study. J Alzheimers Dis. 2014;40:285–95.
Article
PubMed
Google Scholar
de Jong LW, van der Hiele K, Veer IM, Houwing JJ, Westendorp RG, Bollen EL, et al. Strongly reduced volumes of putamen and thalamus in Alzheimer’s disease: an MRI study. Brain. 2008;131:3277–85.
Article
PubMed
PubMed Central
Google Scholar
Nasrabady SE, Rizvi B, Goldman JE, Brickman AM. White matter changes in Alzheimer’s disease: a focus on myelin and oligodendrocytes. Acta Neuropathol Commun. 2018;6:22.
Article
PubMed
PubMed Central
CAS
Google Scholar
Huang KL, Marcora E, Pimenova AA, Di Narzo AF, Kapoor M, Jin SC, et al. A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer’s disease. Nat Neurosci. 2017;20:1052–61.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yuan XZ, Sun S, Tan CC, Yu JT, Tan L. The role of ADAM10 in Alzheimer’s disease. J Alzheimers Dis. 2017;58:303–22.
Article
PubMed
Google Scholar
Vassar R. ADAM10 prodomain mutations cause late-onset Alzheimer’s disease: not just the latest FAD. Neuron. 2013;80:250–3.
Article
CAS
PubMed
PubMed Central
Google Scholar
Miguel RF, Pollak A, Lubec G. Metalloproteinase ADAMTS-1 but not ADAMTS-5 is manifold overexpressed in neurodegenerative disorders as Down syndrome, Alzheimer’s and Pick’s disease. Brain Res Mol Brain Res. 2005;133:1–5.
Article
CAS
PubMed
Google Scholar
Wang HF, Wan Y, Hao XK, Cao L, Zhu XC, Jiang T, et al. Bridging integrator 1 (BIN1) genotypes mediate Alzheimer’s disease risk by altering neuronal degeneration. J Alzheimers Dis. 2016;52:179–90.
Article
PubMed
CAS
Google Scholar
McMillan CT, Lee EB, Jefferson-George K, Naj A, Van Deerlin VM, Trojanowski JQ, et al. Alzheimer’s genetic risk is reduced in primary age-related tauopathy: a potential model of resistance? Ann Clin Transl Neurol. 2018;5:927–34.
Article
CAS
PubMed
PubMed Central
Google Scholar
Dourlen P, Fernandez-Gomez FJ, Dupont C, Grenier-Boley B, Bellenguez C, Obriot H, et al. Functional screening of Alzheimer risk loci identifies PTK2B as an in vivo modulator and early marker of tau pathology. Mol Psychiatry. 2017;22:874–83.
Article
CAS
PubMed
Google Scholar
Yu L, Chibnik LB, Srivastava GP, Pochet N, Yang J, Xu J, et al. Association of Brain DNA methylation in SORL1, ABCA7, HLA-DRB5, SLC24A4, and BIN1 with pathological diagnosis of Alzheimer disease. JAMA Neurol. 2015;72:15–24.
Article
PubMed
PubMed Central
Google Scholar
Kraja AT, Borecki IB, Tsai MY, Ordovas JM, Hopkins PN, Lai CQ, et al. Genetic analysis of 16 NMR-lipoprotein fractions in humans, the GOLDN study. Lipids. 2013;48:155–65.
Article
CAS
PubMed
Google Scholar
Furney SJ, Simmons A, Breen G, Pedroso I, Lunnon K, Proitsi P, et al. Genome-wide association with MRI atrophy measures as a quantitative trait locus for Alzheimer’s disease. Mol Psychiatry. 2011;16:1130–8.
Article
CAS
PubMed
Google Scholar
Chauhan G, Adams HHH, Bis JC, Weinstein G, Yu L, Toglhofer AM, et al. Association of Alzheimer’s disease GWAS loci with MRI markers of brain aging. Neurobiol Aging. 2015;36:1765 e7–e16.
Article
CAS
Google Scholar
Li JQ, Wang HF, Zhu XC, Sun FR, Tan MS, Tan CC, et al. GWAS-linked loci and neuroimaging measures in Alzheimer’s disease. Mol Neurobiol. 2017;54:146–53.
Article
CAS
PubMed
Google Scholar
Espinosa A, Hernandez-Olasagarre B, Moreno-Grau S, Kleineidam L, Heilmann-Heimbach S, Hernandez I, et al. Exploring genetic associations of Alzheimer’s disease loci with mild cognitive impairment neurocognitive endophenotypes. Front Aging Neurosci. 2018;10:340.
Article
CAS
PubMed
PubMed Central
Google Scholar
Medoro A, Bartollino S, Mignogna D, Marziliano N, Porcile C, Nizzari M, et al. Proteases upregulation in sporadic Alzheimer’s disease brain. J Alzheimers Dis. 2019;68:931–8.
Article
CAS
PubMed
Google Scholar
Wilcock DM. Neuroinflammation in the aging Down syndrome brain; lessons from Alzheimer’s disease. Curr Gerontol Geriatr Res. 2012;2012:170276.
Article
PubMed
PubMed Central
Google Scholar
Barron AM, Garcia-Segura LM, Caruso D, Jayaraman A, Lee JW, Melcangi RC, et al. Ligand for translocator protein reverses pathology in a mouse model of Alzheimer’s disease. J Neurosci. 2013;33:8891–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nettiksimmons J, Tranah G, Evans DS, Yokoyama JS, Yaffe K. Gene-based aggregate SNP associations between candidate AD genes and cognitive decline. Age (Dordr). 2016;38:41.
Article
CAS
Google Scholar
Shulman JM, Imboywa S, Giagtzoglou N, Powers MP, Hu Y, Devenport D, et al. Functional screening in Drosophila identifies Alzheimer’s disease susceptibility genes and implicates Tau-mediated mechanisms. Hum Mol Genet. 2014;23:870–7.
Article
CAS
PubMed
Google Scholar
Ou YN, Xu W, Li JQ, Guo Y, Cui M, Chen KL, et al. FDG-PET as an independent biomarker for Alzheimer’s biological diagnosis: a longitudinal study. Alzheimers Res Ther. 2019;11:57.
Article
PubMed
PubMed Central
CAS
Google Scholar